Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
by
Wang, Nan
, Tong, Xinya
, Xue, Xiangyang
, Ye, Lele
, Fang, Su
, Zou, Ruanmin
, Hu, Yingying
, Wu, Su-Ni
, Pan, Kan
, Tang, Sangsang
, Zhang, Haoke
, Guo, Gangqiang
, Chen, Su
, Feng, Shiyu
, Xiang, Dan
, Shi, Xinyu
in
Adenosine
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Breast cancer
/ Carcinoma, Ovarian Epithelial
/ Cell cycle
/ Colorectal cancer
/ Correlation analysis
/ Enzymes
/ Female
/ Gene expression
/ Humans
/ immune microenvironment
/ Immunology
/ Immunotherapy
/ Kinases
/ lncRNA
/ Malignancy
/ Medical prognosis
/ MicroRNAs
/ N6-methyladenosine
/ Non-coding RNA
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - therapy
/ Polymerase chain reaction
/ Prediction models
/ Prognosis
/ Proteins
/ Regression analysis
/ Reproducibility of Results
/ RNA modification
/ RNA modification writers
/ RNA, Long Noncoding - genetics
/ serous ovarian carcinoma
/ Signal transduction
/ Writers
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
by
Wang, Nan
, Tong, Xinya
, Xue, Xiangyang
, Ye, Lele
, Fang, Su
, Zou, Ruanmin
, Hu, Yingying
, Wu, Su-Ni
, Pan, Kan
, Tang, Sangsang
, Zhang, Haoke
, Guo, Gangqiang
, Chen, Su
, Feng, Shiyu
, Xiang, Dan
, Shi, Xinyu
in
Adenosine
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Breast cancer
/ Carcinoma, Ovarian Epithelial
/ Cell cycle
/ Colorectal cancer
/ Correlation analysis
/ Enzymes
/ Female
/ Gene expression
/ Humans
/ immune microenvironment
/ Immunology
/ Immunotherapy
/ Kinases
/ lncRNA
/ Malignancy
/ Medical prognosis
/ MicroRNAs
/ N6-methyladenosine
/ Non-coding RNA
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - therapy
/ Polymerase chain reaction
/ Prediction models
/ Prognosis
/ Proteins
/ Regression analysis
/ Reproducibility of Results
/ RNA modification
/ RNA modification writers
/ RNA, Long Noncoding - genetics
/ serous ovarian carcinoma
/ Signal transduction
/ Writers
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
by
Wang, Nan
, Tong, Xinya
, Xue, Xiangyang
, Ye, Lele
, Fang, Su
, Zou, Ruanmin
, Hu, Yingying
, Wu, Su-Ni
, Pan, Kan
, Tang, Sangsang
, Zhang, Haoke
, Guo, Gangqiang
, Chen, Su
, Feng, Shiyu
, Xiang, Dan
, Shi, Xinyu
in
Adenosine
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Breast cancer
/ Carcinoma, Ovarian Epithelial
/ Cell cycle
/ Colorectal cancer
/ Correlation analysis
/ Enzymes
/ Female
/ Gene expression
/ Humans
/ immune microenvironment
/ Immunology
/ Immunotherapy
/ Kinases
/ lncRNA
/ Malignancy
/ Medical prognosis
/ MicroRNAs
/ N6-methyladenosine
/ Non-coding RNA
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - therapy
/ Polymerase chain reaction
/ Prediction models
/ Prognosis
/ Proteins
/ Regression analysis
/ Reproducibility of Results
/ RNA modification
/ RNA modification writers
/ RNA, Long Noncoding - genetics
/ serous ovarian carcinoma
/ Signal transduction
/ Writers
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
Journal Article
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Serous ovarian carcinoma (SOC) is a gynecological malignancy with high mortality rates. Currently, there is a lack of reliable biomarkers for accurate SOC patient prognosis. Here, we analyzed SOC RNA-Seq data from The Cancer Genome Atlas (TCGA) to identify prognostic biomarkers. Through the pearson correlation analysis, univariate Cox regression analysis, and LASSO-penalized Cox regression analysis, we identified nine lncRNAs significantly associated with four types of RNA modification writers (m 6 A, m 1 A, APA, and A-I) and with the prognosis of SOC patients ( P < 0.05). Six writer-related lncRNAs were ultimately selected following multivariate Cox analysis. We established a risk prediction model based on these six lncRNAs and evaluated its prognostic value in multiple groups (training set, testing set, and entire set). Our risk prediction model could effectively predict the prognosis of SOC patients with different clinical characteristics and their responses to immunotherapy. Lastly, we validated the predictive reliability and sensitivity of the lncRNA-based model via a nomogram. This study explored the association between RNA modification writer-related lncRNAs and SOC prognosis, providing a potential complement for the clinical management of SOC patients.
Publisher
Frontiers Media SA,Frontiers Media S.A
MBRLCatalogueRelatedBooks
This website uses cookies to ensure you get the best experience on our website.